Adam Bisaga, MD
New York State Psychiatric Institute
Division on Substance Abuse
Edward V. Nunes, Jr., MD
Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute
Inpatient programs are important portals for increasing access to treatment. However, most individuals with opioid use disorder are detoxified but not offered medications to prevent relapse. This randomized-controlled trial will examine whether a rapid-transition protocol to inducting extended release naltrexone (XR-NTX) following detoxification yields a higher proportion of patients successfully receiving the first injection of XR-NTX compared to standard detoxification and naltrexone initiation. This study will also assess facilitators and barriers to implementing rapid XR-NTX initiation. The overall goal is to foster widespread adoption of a 5-7-day protocol for initiation of treatment with XR-NTX at Inpatient/Residential programs.
Funded by the NIH HEAL InitiativeSM.
All Participating Nodes: